Literature DB >> 3278225

The S-antigen of Plasmodium falciparum Palo Alto represents a new S-antigen serotype.

D Mattei1, G Langsley, C Braun-Breton, M Guillotte, J F Dubremetz, O Mercereau-Puijalon.   

Abstract

The S-antigen from the Palo Alto isolate of Plasmodium falciparum has been characterized. The partial sequence for the gene coding for this antigen (clone 281) reveals the presence of tandem repeats of eight amino acids which defines a new S-antigen serotype. Antibodies raised against the 281 recombinant clone reacted with a 140 kDa antigen by immunoblotting with parasite extracts and culture supernatants. The 140 kDa peptide was also identified by immunoprecipitation of metabolic labelled parasites. The 281 mouse antiserum was used to localize the antigen on parasite smears by indirect immunofluorescence assay and more precisely by immunoelectron microscopy. The S-antigen is localized within the parasitophorous vacuole. Furthermore, different isolates were examined for the presence of the Palo Alto S-antigen specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278225     DOI: 10.1016/0166-6851(88)90036-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Novel target antigens of the variant-specific immune response to Plasmodium falciparum identified by differential screening of an expression library.

Authors:  C Le Scanf; T Fandeur; S Bonnefoy; M Guillotte; O Mercereau-Puijalon
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  The gene coding for the 190,000-dalton iron-regulated protein of Yersinia species is present only in the highly pathogenic strains.

Authors:  E Carniel; O Mercereau-Puijalon; S Bonnefoy
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

3.  The 11-1 gene of Plasmodium falciparum codes for distinct fast evolving repeats.

Authors:  A Scherf; C Hilbich; K Sieg; D Mattei; O Mercereau-Puijalon; B Müller-Hill
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

4.  Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector.

Authors:  V A Snewin; S Premawansa; G M Kapilananda; L Ratnayaka; P V Udagama; D M Mattei; E Khouri; G Del Giudice; J S Peiris; K N Mendis; P H David
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.